Evidence map›Paper›PMID 39815178›Full record

ArticleBMC musculoskeletal disorders2025

Tibial tubercle transfer SurgeRy and physiothErapy Versus physIotherapy only for chronic paTellofemorAL paIn: study protocol for a randomiSed controllEd trial (REVITALISE).

Myrthe P F van de Ven, Martin Ophey, Victor van de Graaf, Sebastiaan A W van de Groes, Marijn Sinkeldam, Charlotte H W Wijers, Sander Koëter

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06227806 (Surgery and Exercise Versus Exercise Only for Chronic Patellofemoral Pain Syndrome), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06227806 naunknown statusnot on this map

Surgery and Exercise Versus Exercise Only for Chronic Patellofemoral Pain Syndrome: a Randomised Controlled Trial

TypeinterventionalSponsorCanisius-Wilhelmina HospitalRan2023 to 2025Enrolled40ConditionsPatellofemoral Pain Syndrome, Tibial Tubercle Transfer, Home Exercise ProgramArmsTibial Tubercle Transfer, Home Exercise Program
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Myrthe P F van de VenDepartment of Orthopaedics, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Martin OpheyDepartment of Orthopaedic Surgery and Sports Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Victor van de GraafDepartment of Orthopaedic Surgery, Bergman Clinics, Braillelaan 10, Rijswijk, 2289 CM, The Netherlands.
Sebastiaan A W van de GroesDepartment of Orthopaedics, Radboud University Medical Centre, Nijmegen, The Netherlands.
Marijn SinkeldamDepartment of Orthopaedics, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Charlotte H W WijersCWZ Academy, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Sander KoëterDepartment of Orthopaedics, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands. s.koeter@cwz.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatellofemoral pain (PFP) is a common musculoskeletal disorder resulting in anterior knee pain. Physiotherapy is the current standard treatment, while surgical intervention (tibial tubercle transfer [TTT]) is reserved for chronic cases when nonoperative treatment has failed. TTT can result in clinically meaningful improvement in patients with patellofemoral maltracking without instability. However, to date, no randomised controlled trials (RCT) have compared TTT combined with a physiotherapy (PT) programme to PT alone as the initial treatment for PFP.

methodsA single-centre nonblinded RCT in 40 patients with chronic PFP (> 1 year) and tibial tubercle-trochlear groove (TT-TG) > 15 mm will be randomised to either TTT followed by PT or to PT alone in a 1:1 ratio in a concealed manner. The primary outcome is knee pain at 18 weeks for the TTT group (6 weeks splint phase + 12 weeks PT) and at 12 weeks for the PT group, measured by the visual analog scale (VAS). Secondary outcomes include Patient-Reported Outcome Measures (PROMs) using the Kujala score, International Knee Documentation Committee (IKDC) 'Subjective Knee Form', Tegner Activity score and EuroQol 5D-5 L for quality of life. Range of motion (ROM) is measured using the decline step-down test (DSDT). Between-group differences will be analysed using multivariable linear regression analysis, while longitudinal differences will be assessed with linear mixed models for repeated measures. The difference in direct medical costs will also be assessed. DISCUSSION: The REVITALISE study is the first randomised study to compare surgical intervention (TTT) followed by PT to PT alone in patients with chronic PFP. This study will generate level-1 evidence on the most effective treatment for chronic PFP, which can be integrated into the national guideline to aid orthopaedic surgeons and physiotherapists in their decision-making and ultimately improve our care for patients with chronic PFP.

trial registrationStudy Identifier NCT06227806, registered on 26 Jan 2024 on ClinicalTrials.gov. The study underwent independent peer review and received approval from the ethical review board (number NL80956.091.22).

Indexed as

Chronic PainPatellofemoral Pain SyndromePhysical Therapy ModalitiesAdultCombined Modality TherapyFemaleHumansMaleMiddle AgedPain MeasurementRandomized Controlled Trials as TopicTreatment OutcomeYoung AdultPatellofemoral painPhysiotherapyRandomised controlled trialTibial tubercle transfer

Identifiers

PMID39815178
PMCPMC11734609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.